Octave Bioscience's Seed VC Round

Octave Bioscience raised a round of funding on September 13, 2017. Investors include Kleiner Perkins Caufield & Byers.

Octave Bioscience is an early stage molecular diagnostics company focused on neurodegenerative diseases and conditions.…

Articles about Octave Bioscience's Seed VC Round: